Novavax's fourth-quarter loss narrowed on Thursday, helped by reduced selling and administrative expenses of COVID-19 ...
House Republicans are urging President Trump to use executive action on COVID-19 mandates for organ transplants.
Novavax's fourth-quarter loss narrowed on Thursday, helped by reduced selling and administrative expenses of COVID-19 ...
Yale researchers have found clues as to why certain people experience adverse health effects after the COVID-19 vaccine, ...
In a small study, Yale researchers have found "differences in immune profiles" among those who have rare reaction to the ...
A small study on Covid vaccine safety has sparked an online tempest — and highlighted the conundrum faced by some scientists.
Robert F. Kennedy Jr, the newly confirmed health secretary for the Trump administration who has called for sweeping policy ...
Novavax reported Q4 sales of $88.31 million, beating estimates despite a decline. The company shifts focus to partnerships ...
Phil Mounteney, who is Dotmatics' vice president of science and technology, says the pandemic showed more relaxed regulations ...
Department of Health and Human Services Secretary Robert F. Kennedy Jr. paused a $240 million contract to create a new ...
Opinion
16hOpinion
The New Republic on MSNRFK Jr. Takes a Sledgehammer to Two Major Vaccine DevelopmentsDonald Trump might as well set up a merch booth in the Oval Office. The president, accompanied by Health Secretary Robert F. Kennedy Jr. and Commerce Secretary Howard Lutnick, decided to hawk some new ...
A recent modification to the contract would have allowed Vaxart to invoice BARDA for the remaining $230 million or so for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results